Jonathan W. Ayers - May 18, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers
Stock symbol
IDXX
Transactions as of
May 18, 2023
Transactions value $
-$8,214,971
Form type
4
Date filed
5/22/2023, 05:00 PM
Previous filing
May 19, 2023
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $795K +10K +7.3% $79.54* 147K May 18, 2023 Direct
transaction IDXX Common Stock Sale -$486K -1K -0.68% $486.48 146K May 18, 2023 Direct F1
transaction IDXX Common Stock Sale -$1.34M -2.75K -1.89% $487.84 143K May 18, 2023 Direct F2
transaction IDXX Common Stock Sale -$494K -1.01K -0.71% $488.63 142K May 18, 2023 Direct F3
transaction IDXX Common Stock Sale -$1.1M -2.24K -1.58% $489.71 140K May 18, 2023 Direct F4
transaction IDXX Common Stock Sale -$832K -1.7K -1.21% $490.77 138K May 18, 2023 Direct F5
transaction IDXX Common Stock Sale -$638K -1.3K -0.94% $491.91 137K May 18, 2023 Direct F6
transaction IDXX Common Stock Options Exercise $795K +10K +7.3% $79.54* 147K May 19, 2023 Direct
transaction IDXX Common Stock Sale -$554K -1.14K -0.77% $486.92 146K May 19, 2023 Direct F7
transaction IDXX Common Stock Sale -$1.1M -2.25K -1.54% $487.82 144K May 19, 2023 Direct F8
transaction IDXX Common Stock Sale -$639K -1.31K -0.91% $488.77 142K May 19, 2023 Direct F9
transaction IDXX Common Stock Sale -$147K -300 -0.21% $490.03 142K May 19, 2023 Direct F10
transaction IDXX Common Stock Sale -$197K -400 -0.28% $491.59 142K May 19, 2023 Direct F11
transaction IDXX Common Stock Sale -$703K -1.43K -1.01% $492.82 140K May 19, 2023 Direct F12
transaction IDXX Common Stock Sale -$607K -1.23K -0.88% $494.28 139K May 19, 2023 Direct F13
transaction IDXX Common Stock Sale -$439K -886 -0.64% $495.94 138K May 19, 2023 Direct F14
transaction IDXX Common Stock Sale -$378K -759 -0.55% $497.66 137K May 19, 2023 Direct F15
transaction IDXX Common Stock Sale -$150K -300 -0.22% $498.48 137K May 19, 2023 Direct F16
holding IDXX Common Stock 450K May 18, 2023 by Jonathan W. Ayers 2022 GRAT F17
holding IDXX Common Stock 10K May 18, 2023 by Ayers Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -10K -8.66% 106K May 18, 2023 Common Stock 10K $79.54 Direct F18, F19
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -10K -9.48% 95.5K May 19, 2023 Common Stock 10K $79.54 Direct F18, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $486.08 to a high of $487.03 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average price of the shares sold ranging from a low of $487.19 to a high of $488.19 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $488.21 to a high of $489.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $489.32 to a high of $490.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $490.375 to a high of $491.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Represents the weighted average price of the shares sold ranging from a low of $491.54 to a high of $492.345 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F7 Represents the weighted average price of the shares sold ranging from a low of $486.29 to a high of $487.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F8 Represents the weighted average price of the shares sold ranging from a low of $487.34 to a high of $488.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F9 Represents the weighted average price of the shares sold ranging from a low of $488.41 to a high of $489.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F10 Represents the weighted average price of the shares sold ranging from a low of $489.865 to a high of $490.11 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F11 Represents the weighted average price of the shares sold ranging from a low of $491.36 to a high of $491.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F12 Represents the weighted average price of the shares sold ranging from a low of $492.38 to a high of $493.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F13 Represents the weighted average price of the shares sold ranging from a low of $493.37 to a high of $494.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F14 Represents the weighted average price of the shares sold ranging from a low of $495.53 to a high of $496.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F15 Represents the weighted average price of the shares sold ranging from a low of $497.00 to a high of $497.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F16 Represents the weighted average price of the shares sold ranging from a low of $498.47 to a high of $498.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F17 The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F18 Grant of option to buy 74,316 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F19 Not applicable.